Category: Pharmaceuticals
Pharmaceuticals market research reports by GlobalData
-
China ICP Procedures Count and Forecast to 2030
China ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “China ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the China ICP Procedures. The China ICP Procedures report provides key information and data on - Procedure volume data for I ... Read More
-
India ICP Procedures Count and Forecast to 2030
India ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “India ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the India ICP Procedures. The India ICP Procedures report provides key information and data on - Procedure volume data for I ... Read More
-
United Kingdom (UK) ICP Procedures Count and Forecast to 2030
United Kingdom (UK) ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “United Kingdom ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United Kingdom ICP Procedures.The United Kingdom ICP Procedures report provides key information a ... Read More
-
United States (US) ICP Procedures Count and Forecast to 2030
United States (US) ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “United States ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United States ICP Procedures. The United States ICP Procedures report provides key information and ... Read More
-
Russia ICP Procedures Count and Forecast to 2030
Russia ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “Russia ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Russia ICP Procedures. The Russia ICP Procedures report provides key information and data on - Procedure volume data f ... Read More
-
Canada ICP Procedures Count and Forecast to 2030
Canada ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “Canada ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Canada ICP Procedures. The Canada ICP Procedures report provides key information and data on - Procedure volume data f ... Read More
-
Spain ICP Procedures Count and Forecast to 2030
Spain ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “Spain ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Spain ICP Procedures. The Spain ICP Procedures report provides key information and data on - Procedure volume data for I ... Read More
-
France ICP Procedures Count and Forecast to 2030
France ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “France ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the France ICP Procedures. The France ICP Procedures report provides key information and data on - Procedure volume data f ... Read More
-
Germany ICP Procedures Count and Forecast to 2030
Germany ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “Germany ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Germany ICP Procedures. The Germany ICP Procedures report provides key information and data on - Procedure volume da ... Read More
-
Brazil ICP Procedures Count and Forecast to 2030
Brazil ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “Brazil ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Brazil ICP Procedures. The Brazil ICP Procedures report provides key information and data on - Procedure volume data f ... Read More
-
Spinal Muscular Atrophy (SMA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Spinal Muscular Atrophy (SMA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in SMA therapeutics. More than 138,844 diagnosed prevalent cases of 5q SMA (types I–IV) ... Read More
-
Australia ICP Procedures Count and Forecast to 2030
Australia ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “Australia ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia ICP Procedures. The Australia ICP Procedures report provides key information and data on - Procedure v ... Read More
-
Fitness - Consumer TrendSights Analysis, 2023
Fitness - Consumer TrendSights Analysis, 2023 Summary Post-pandemic, fitness which entails prioritizing care for the individuals health needs is more important than ever. Modern fitness trends adhere to a self-care and holistic health approach. Consumers are taking ownership of the health crisis and ... Read More
-
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Exc ... Read More
-
von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032
von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032 Summary The prevalence of vWD is increasing at a steady rate, in line with population growth in the 3MM, at an AGR of 0.61%. Currently, the treatment regime ... Read More
-
Primary Immune Deficiency (PID) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Primary Immune Deficiency (PID) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PID therapeutics. More than 325,500 diagnosed prevalent cases are anticipated in 2 ... Read More
-
Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review
Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Clinical Trials - Precision and Personalized Medicine
Clinical Trials - Precision and Personalized Medicine Summary This report provides analysis of clinical research involving precision and personalized medicines and identifies trends throughout the years. The terms precision and personalized medicine are often used interchangeably as they refer to si ... Read More
-
Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review
Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products ... Read More
-
Nebulizer Systems Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Nebulizer Systems Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Nebulizer Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Re ... Read More
-
Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regu ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PTSD therapeutics. Scope GlobalData’s PTSD: Competitive Landscape combines d ... Read More
-
Acura Pharmaceuticals Inc (ACUR) - Financial and Strategic SWOT Analysis Review
Acura Pharmaceuticals Inc (ACUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea ... Read More
-
Celiac Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Celiac Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Celiac Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Spon ... Read More
-
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and ... Read More
Research Assistance
